azathioprine has been researched along with Kahler Disease in 10 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A current southeastern cancer study group protocol for the treatment of multiple myeloma involves induction with BCNU, cyclophosphamide, and prednisone (BCP) and maintenance with either melphalan and prednisone (MP), prednisone, Adriamycin, imuran, and vincristine (PAIV), or delayed treatment of relapsed cases following induction." | 7.66 | Assessment of myeloma maintenance regimen of prednisone. Adriamycin, imuran, and vincristine in a murine plasmacytoma model. ( Cohen, HJ; Durant, JR; Ghanta, VK; Hiramoto, RN; Silberman, HR, 1981) |
| "A randomized study compared the response of patients with multiple myeloma to chlorambucil, melphalan, and azathioprine." | 5.04 | Treatment of myeloma. Comparison of melphalan, chlorambucil, and azathioprine. ( , 1975) |
| " Four case reports are presented; 3 lymphomas and 1 multiple myeloma that developed, in heart transplant recipients receiving triple-drug immunosuppression: azathioprine, cyclosporine and prednisolone." | 3.68 | [Lymphoproliferative syndromes after cardiac transplantation and treatment with cyclosporine. Report of 4 cases]. ( Burtin, P; Guerci, AP; Lederlin, P; Mattei, S, 1992) |
| "A current southeastern cancer study group protocol for the treatment of multiple myeloma involves induction with BCNU, cyclophosphamide, and prednisone (BCP) and maintenance with either melphalan and prednisone (MP), prednisone, Adriamycin, imuran, and vincristine (PAIV), or delayed treatment of relapsed cases following induction." | 3.66 | Assessment of myeloma maintenance regimen of prednisone. Adriamycin, imuran, and vincristine in a murine plasmacytoma model. ( Cohen, HJ; Durant, JR; Ghanta, VK; Hiramoto, RN; Silberman, HR, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (80.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tribalto, M | 1 |
| Arcese, W | 1 |
| Colombo, R | 1 |
| Pastore, S | 1 |
| Franchii, A | 1 |
| Ghanta, VK | 1 |
| Cohen, HJ | 2 |
| Silberman, HR | 2 |
| Durant, JR | 1 |
| Hiramoto, RN | 1 |
| Kathol, RC | 1 |
| Hamilton, HE | 1 |
| Sieber, SM | 1 |
| Alexanian, R | 1 |
| Salmon, S | 1 |
| Bonnet, J | 1 |
| Gehan, E | 1 |
| Haut, A | 1 |
| Weick, J | 1 |
| Salmon, SE | 1 |
| Durie, BG | 1 |
| Guerci, AP | 1 |
| Burtin, P | 1 |
| Mattei, S | 1 |
| Lederlin, P | 1 |
| McElwain, TJ | 1 |
| Meldrum, M | 1 |
| Gore, ME | 1 |
| Millar, BC | 1 |
| Malpas, JS | 1 |
| Bartolucci, AA | 1 |
| Forman, WB | 1 |
2 reviews available for azathioprine and Kahler Disease
| Article | Year |
|---|---|
[Chemotherapy of multiple myeloma. Review of the recent trials].
Topics: Antineoplastic Agents; Azathioprine; Carmustine; Chlorambucil; Cyclophosphamide; Drug Therapy, Combi | 1981 |
The action of antitumor agents: a double-edged sword?
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Azathioprine; Burkitt Lymphoma; Choriocarcinoma; | 1977 |
3 trials available for azathioprine and Kahler Disease
| Article | Year |
|---|---|
Combination therapy for multiple myeloma.
Topics: Antineoplastic Agents; Azathioprine; Carmustine; Cyclophosphamide; Doxorubicin; Drug Therapy, Combin | 1977 |
Treatment of myeloma. Comparison of melphalan, chlorambucil, and azathioprine.
Topics: Azathioprine; Blood Urea Nitrogen; Bone Neoplasms; Chlorambucil; Drug Therapy, Combination; Fluoxyme | 1975 |
Consolidation and maintenance therapy in multiple myeloma: randomized comparison of a new approach to therapy after initial response to treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Azathioprine; Carmustine; Clinical Trials as Topic; | 1986 |
5 other studies available for azathioprine and Kahler Disease
| Article | Year |
|---|---|
Assessment of myeloma maintenance regimen of prednisone. Adriamycin, imuran, and vincristine in a murine plasmacytoma model.
Topics: Animals; Antineoplastic Agents; Azathioprine; Doxorubicin; Drug Therapy, Combination; Female; Humans | 1981 |
Azathioprine-induced plasmacytosis.
Topics: Arthritis, Rheumatoid; Azathioprine; Bone Marrow Cells; Diagnosis, Differential; Female; Humans; Mid | 1981 |
Cellular kinetics in multiple myeloma. A new approach to staging and treatment.
Topics: Azathioprine; Bone and Bones; Bone Neoplasms; Cell Count; Computers; Cytarabine; Diagnosis, Computer | 1975 |
[Lymphoproliferative syndromes after cardiac transplantation and treatment with cyclosporine. Report of 4 cases].
Topics: Adult; Azathioprine; Cyclosporine; Drug Therapy, Combination; Heart Transplantation; Humans; Immunos | 1992 |
Intensive therapy for myeloma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Azathioprine; Bone Marrow Transplantation; Humans; M | 1990 |